1.
Chinese Journal of Geriatrics
;
(12)2001.
Artigo
em Chinês
| WPRIM
| ID: wpr-675921
RESUMO
0.05).There was significant difference in the 3-year survival rate between A and C group. Conclusions The 3-year survival rate was dramatically increased with combined therapy mainly by cisplatin, the dose of 60~80mg is tolerant for the elderly aged above seventy years, and perioperation complications can be cured.